PharmEasy has filed for its IPO — these are the key takeaways from its DRHP

• PharmEasy plans to raise ₹ 6,250 crore through its public issue.
• The company will use this capital to acquire new businesses and repay loans.
• Its consolidated revenue tripled to ₹2360 crore in the financial year 2021.

PharmEasy is all set to make its public debut to raise ₹ 6,250 crore in an initial public offering (IPO).

The online pharmacy startup, run by API Holdings, filed its draft red herring prospectus (DRHP) with the market regulator Securities and Exchange Board of India (SEBI) on November 10.

The company will be raising this amount as a fresh issue and none of its existing stakeholders would be selling their shareholdings.

PharmEasy, in consultation with the bankers to the issue, may consider a private placement aggregating up to ₹1,250 crore. If such placement is completed, the fresh issue size will be reduced.